Pingora Partners LLC Bio Cardia, Inc. Transaction History

Pingora Partners LLC

  • $141 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$0.38 - $0.68 $3,111 - $5,567
8,188 Added 110.4%
15,605 $6.35 Million
Q4 2023

Feb 12, 2024
BUY
$0.37 - $1.07 $2,744 - $7,936
7,417 New
7,417 $4.93 Million

About BioCardia, Inc.

BCDA Quotes by TradingView
  • Ticker BCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,758,200
  • Market Cap $39.8M
  • Description
  • BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...
More about BCDA
Track This Portfolio

Track Pingora Partners LLC Portfolio

Follow Pingora Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pingora Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pingora Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email